OraSure Technologies, Inc. (OSUR)
After hours:
Chart Events
Performance Outlook
| Previous Close | 4.3200 |
| Open | 4.2900 |
| Bid | 4.1400 x 3100 |
| Ask | 4.1800 x 3000 |
| Day's Range | 4.1400 - 4.3200 |
| 52 Week Range | 2.6200 - 13.5700 |
| Volume | |
| Avg. Volume | 1,614,180 |
| Market Cap | 301.121M |
| Beta (5Y Monthly) | 0.01 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.1570 |
| Earnings Date | Feb 28, 2022 - Mar 04, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 7.00 |
- Simply Wall St.
Analysts Just Published A Bright New Outlook For OraSure Technologies, Inc.'s (NASDAQ:OSUR)
OraSure Technologies, Inc. ( NASDAQ:OSUR ) shareholders will have a reason to smile today, with the analysts making...
- Zacks
OraSure Technologies (OSUR) Reports Break-Even Earnings for Q2
OraSure (OSUR) delivered earnings and revenue surprises of 100% and 13.16%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
- GlobeNewswire
OraSure Reports 2Q22 Record Revenue of $80.2 Million Growing 39% Year-Over-Year
InteliSwab® revenue of $43.1 million in Q2, up 95% sequentially with significant scaling in production InteliSwab® gross margins improve sequentially by over 2,000 basis points GAAP gross margin of 34.4%, a decrease of 200 basis points sequentially; non-GAAP gross margins improve 250 basis points sequentially to 40.1% despite headwinds Q2 GAAP EPS of ($0.26) and non-GAAP EPS of ($0.00) Company expects to generate positive cash flow in the 4Q22 Announces strategic transformation, including appoin
